MedPath

Edonerpic

Generic Name
Edonerpic
Drug Type
Small Molecule
Chemical Formula
C16H21NO2S
CAS Number
519187-23-6
Unique Ingredient Identifier
QY49O94S2W

Overview

Edonerpic is a neurotrophic agent intended for the treatment of Alzheimer's disease which is under phase I clinical trial.

Background

Edonerpic is a neurotrophic agent intended for the treatment of Alzheimer's disease which is under phase I clinical trial.

Indication

Investigated for use/treatment in alzheimer's disease.

Associated Conditions

No associated conditions information available.

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath